Physician

Alan Joel Ruby, MD

According to 2025 Medicare claims, Alan Ruby, MD (NPI: 1801828025) practices ophthalmology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS, PC (NPI: 1215003793; TIN: 381946761) and primary practice location at 48307-1873.

Ruby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 894 traditional Medicare patients, billed 25,728 HCPCS/CPT codes, and received $2,353,173 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 351 prescription claims across 120 beneficiaries totaling $18,270 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 24 records totaling $2,349. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $3,312,853 to $2,353,173. Similarly, Part D prescription costs have fallen sharply in recent years, from $24,889 to $18,270. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.7M2015 Medicare payment: $3,312,853 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,585,264 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,724,484 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,573,423 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,236,919 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,655,778 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,848,740 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,574,104 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,434,349 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,353,173 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,29917,288$3,312,853
20161,34917,905$3,585,264
20171,27819,004$3,724,484
20181,15718,572$3,573,423
20191,06617,439$3,236,919
202099412,866$2,655,778
202195113,243$2,848,740
202292713,552$2,574,104
202389221,584$2,434,349
202489425,728$2,353,173

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$43K2015 Drug cost: $24,889 (USD; Tot_Drug_Cst)2016 Drug cost: $37,102 (USD; Tot_Drug_Cst)2017 Drug cost: $37,537 (USD; Tot_Drug_Cst)2018 Drug cost: $31,597 (USD; Tot_Drug_Cst)2019 Drug cost: $33,429 (USD; Tot_Drug_Cst)2020 Drug cost: $43,103 (USD; Tot_Drug_Cst)2021 Drug cost: $40,714 (USD; Tot_Drug_Cst)2022 Drug cost: $28,906 (USD; Tot_Drug_Cst)2023 Drug cost: $18,861 (USD; Tot_Drug_Cst)2024 Drug cost: $18,270 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015131366$24,889
2016164465$37,102
2017151431$37,537
2018161499$31,597
2019171602$33,429
2020143505$43,103
2021133451$40,714
2022124394$28,906
202393263$18,861
2024120351$18,270

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1681,640$650
67028Injection of drug into eye3181,444$103
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4661,497$100
92014Established patient complete exam of visual system357439$91
92134Imaging of retina7582,149$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate621,951$6,093
Prednisolone AcetatePrednisolone Acetate874,561$4,394
Ketorolac TromethamineKetorolac Tromethamine422,319$1,061
Brimonidine TartrateBrimonidine Tartrate412,731$800
ErythromycinErythromycin Base22182$346

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$2,349Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan Joel Ruby, MD?

Tedicare shows public-source Medicare data for Alan Joel Ruby, MD (NPI 1801828025), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Joel Ruby, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Joel Ruby, MD?

Alan Joel Ruby, MD is linked to ASSOCIATED RETINAL CONSULTANTS, PC (billing NPI 1215003793) in the available physician profile data.

Does Alan Joel Ruby, MD have Open Payments data?

Alan Joel Ruby, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.